Myeloid sarcoma is a rare disease that can present as an isolated extramedullary leukemic
tumor, concurrently with or at relapse of acute myeloid leukemia. Owing to the rarity of this …

Thirty-two cases of granulocytic sarcoma (GS) are reported in this paper. Age range was
from 16–70 years. GS was accompanied by AML in 13 cases, ALL (My+) in one case, CML …

Myeloid sarcoma (MS) is a rare neoplasm whose knowledge is largely based on case
reports and/or technically dated contributions. Ninety-two MSs in adulthood with clinical data …

Paraffin-section immunohistochemical analysis was performed using a monoclonal antibody
against CD163 to evaluate the antibody's usefulness in identifying cells of monocyte …

Context.—A complete diagnosis of acute leukemia requires knowledge of clinical
information combined with morphologic evaluation, immunophenotyping and karyotype …

CD79 is composed of CD79a and CD79b components expressed almost exclusively on B
cells and B-cell neoplasms. CD79a and CD79b expression precedes immunoglobulin (Ig) …

Granulocytic sarcoma (GS) is an extramedullary tumor composed of immature myeloid cells.
The objectives of this study were to describe the frequency, presenting characteristics, and …

BACKGROUND. It is unknown whether patients with nonleukemic myeloid sarcoma (MS)
and those with acute myeloid leukemia (AML) have similar responses to anti‐AML treatment …

Purpose: To investigate the possible prognostic factors of survival outcomes in patients with
granulocytic sarcoma (GS). Methods: We retrospectively investigated the prognostic factors …

Myeloid sarcoma (MS) is an extramedullary tumor of immature myeloid cells. We analyzed
131 patients with MS, including:(1) de novo MS;(2) MS with concomitant acute myeloid …